The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2026.
Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2021 to 2026. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market-driving forces is also provided.
The publisher examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries and software; as well as the agriculture; consumer products, cosmetics and skin care, food and beverage, healthcare and industrial chemicals enable product sectors.
The role of key strategic alliances and acquisitions from 2018 to 2020 is discussed. Emerging markets, including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops and chassis organisms; as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals, are analyzed, and more than 215 companies in these fields are highlighted.
Report Includes
- 30 data tables and 99 additional tables
- An up-to-date review and analysis of the global market for synthetic biology within the life science industry
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global synthetic biology market size, forecasted growth trends, and corresponding market share analysis by product type, end-user industry, and region
- Highlights of the current and future market potential for synthetic biology products and technologies, and areas of focus to forecast this market into various segments and sub-segments
- Description of core synthetic biology products, key enabling technologies, and identify commercial opportunities for product development and competitive strategies
- In-depth assessment of the synthetic biology industry structure, competitors review, and intellectual property landscape
- Information on synthetic biology industry M&A deals, development of commercially viable products and technologies, and other strategic alliances within the industry
- Patent review and analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene-editing industry
- Detailed profiles of about 185+ companies within synthetic biology industry. Major players include Agilent Technologies Inc., Eurofins Scientific, GenScript, Merck KGaA, Novozymes A/S, Thermo Fisher Scientific Inc., and Twist Bioscience
What is the estimated value of the Global Synthetic Biology Market?
What is the growth rate of the Global Synthetic Biology Market?
What is the forecasted size of the Global Synthetic Biology Market?
Who are the key companies in the Global Synthetic Biology Market?
Report Attribute | Details |
---|---|
No. of Pages | 344 |
Published | February 2022 |
Forecast Period | 2021 - 2026 |
Estimated Market Value ( USD | $ 9.5 Billion |
Forecasted Market Value ( USD | $ 33.2 Billion |
Compound Annual Growth Rate | 28.4% |
Regions Covered | Global |
No. of Companies Mentioned | 186 |
Table of Contents
Samples
LOADING...
Executive Summary
The synthetic biology industry is a prime growth opportunity due to several factors. First, many of the applications for synthetic biology have large addressable markets and the penetration rate is still modest; the industry will experience explosive growth as these penetration rates accelerate. Second, development of exciting new technologies is driving innovation within the industry. These technologies include ultra-high-throughput screening platforms for organism design, enzymatic DNA synthesis and novel gene editing platforms. Third, the industry is focusing on value-added products, placing less emphasis on cost-sensitive, commodity products.Synthetic biology foundries now routinely design, build and test designer organisms capable of producing valuable end products. The workflow includes modifying the genomes of these organisms to produce just the right combination of taste and texture, as for the food industry. Designer organisms in the textile industry help achieve the right combination of strength, flexibility, weight, dimensional variability, and targeted surface and structural modification. High-value synthetic biology end products such as these are forecast to drive significant market growth in this industry.
This report provides in-depth coverage of the dynamic synthetic biology industry, including insights into its component technologies and market segments, as well as its leading participants.
The synthetic biology industry consists of three main sets of technologies and products: enabling, core and enabled. Enabling technologies and products are the engines that drive the development of the synthetic biology industry. Core products and technologies, including standardized DNA parts, synthetic genes and chassis organisms, are the key tools by which cellular factories and systems produce enabled products.
Synthetic biology-enabled products (e.g., pharmaceuticals, chemicals, biofuels, agricultural, textiles, food) have large downstream market potential. Synthetic biology technologies add value in each of these downstream industries. In agriculture, synthetic biology makes it possible to produce crops with desired traits, such as pest resistance or high yields. Synthetic biology allows for the production of foods free of animal products, meeting an emerging consumer need in this industry.
Companies Mentioned
- 20N Labs Inc.
- Abeona Therapeutics LLC
- Active Motif
- Aemetis Inc.
- Agilent Technologies Inc.
- Agrivida Inc.
- Ajinomoto Co. Inc.
- Algenuity
- Ambrx Inc.
- Amfora Inc.
- Amyris Inc.
- Ansa Biotechnologies Inc.
- Antheia Inc.
- Arbor Biotechnologies Inc.
- Arcadia Biosciences Inc.
- Arcturus Therapeutics Inc.
- Ardra Bio Inc.
- Arzeda Corp.
- Astrazeneca plc
- Atg Biosynthetics GmbH
- Atum
- Avecia
- Azargen Biotechnologies Pty. Ltd.
- Azitra Inc.
- Basf AG
- Bayer AG
- Beam Therapeutics Inc.
- Benchling
- Benson Hill Biosystems Inc.
- Bio Basic Inc.
- Bio S&T Inc.
- Biogen Inc.
- Biomax Informatics AG
- Biomx Ltd.
- Bioneer Corp.
- Biosyntia Aps
- Bluebird Bio Inc.
- Bolt Threads Inc.
- Bristol-Myers Squibb Co.
- C-Lecta GmbH
- Calysta Inc.
- Calyxt Inc.
- Cargill Inc.
- Caribou Biosciences Inc.
- Caszyme
- Catalog Technologies, Inc.
- Cellectis Sa
- Centrient Pharmaceuticals
- Chain Biotechnology Ltd.
- Cibus Inc.
- Codagenix Inc.
- Codexis Inc.
- Colorifix Ltd.
- Corbion
- Crispr Therapeutics
- Cronos Group
- Crown Laboratories Inc.
- Danaher Corp.
- Demuris Ltd.
- Dna Script
- Dovetail Genomics LLC
- Dowdupont Inc.
- Edigene Inc.
- Editas Medicine Inc.
- Eligo Bioscience Sas
- Endless West
- Enevolv Inc.
- Epoch Life Science Inc.
- Eurofins Scientific
- Evolva Sa
- Evonetix
- Exxonmobil Corp.
- G+Flas Life Sciences Inc.
- Gea Enzymes
- Geltor Inc.
- Genemed Synthesis Inc.
- Generay Biotech Co. Ltd.
- Genomatica
- Genscript
- Genus plc
- Gevo Inc.
- Gilead Sciences Inc.
- Ginkgo Bioworks
- GlaxoSmithKline plc
- Global Bioenergies
- Glowee- Unreasonable Group
- Glycosbio Food Sciences
- Glycosyn LLC
- Goodyear Tire & Rubber Co.
- Helixworks Technologies Ltd.
- Homology Medicines Inc.
- Horizon Discovery Group plc
- Huvepharma
- Illumina Inc.
- Impossible Foods Inc.
- Industrial Microbes Inc.
- Ingenza Ltd.
- Inovio Pharmaceuticals Inc.
- Inscripta Inc.
- Intellia Therapeutics Inc.
- International Business Machines
- Joyn Bio
- Kaneka Corp.
- Kws Saat Se
- Labgenius Ltd.
- Lanzatech
- Lattice Automation Inc.
- Lc Sciences
- Lcy Chemical Corp.
- Lgc Group
- Locus Biosciences
- Logicbio Therapeutics
- Lumen Bioscience
- Lygos Inc.
- Meissa Vaccines, Inc.
- Merck Kgaa
- Microbyre, Inc.
- Microsoft Corp.
- Microsynbiotix
- Milis Bio Ltd.
- Modern Meadow
- Modular Genetics Inc.
- Molecular Assemblies Inc.
- Morphosys AG
- Motif Ingredients
- New England Biolabs
- Novartis Pharma AG
- Novome Biotechnologies Inc.
- Novozymes A/S
- Novvi LLC
- Nucelis LLC
- Nuclera Nucleics Ltd.
- Omega Bio-Tek Inc.
- Oragenics Inc.
- Oxford Biomedica plc
- Pairwise Plants Inc.
- Pfizer Inc.
- Phio Pharmaceuticals Corp.
- Phytowelt Green Technologies GmbH
- Pivot Bio
- Poseida Therapeutics Inc.
- Precision Biosciences Inc.
- Prokarium Holdings Ltd.
- Promega Corp.
- Ptc Therapeutics Inc.
- Recombinetics Inc.
- Roquette Freres
- Royal Dsm Nv
- Sangamo Therapeutics Inc.
- Sarepta Therapeutics Inc.
- Scarab Genomics LLC
- Senti Biosciences
- Sherlock Biosciences
- Shinegene Molecular Bio-Technologies Inc.
- Sigma Aldrich Corp.
- Silicolife Lda.
- Socati Corp.
- Spiber Inc.
- String Bio
- Sugarlogix
- Synbio Technologies Inc.
- Syngenta AG (Chemchina)
- Synlogic Therapeutics
- Synthace Ltd.
- Synthego Corp.
- Synthetic Biologics Inc.
- Takara Bio
- Tepha Inc.
- Teselagen Biotechnology Inc.
- Thermo Fisher Scientific Inc.
- Tierra Biosciences
- Toolgen
- Transcriptic Inc.
- Triton Algae Innovations Ltd.
- Tropic Biosciences U.K. Ltd.
- Twist Bioscience
- Vedanta Biosciences
- Versalis Spa
- Vertex Pharmaceuticals Inc.
- Vir Biotechnology Inc.
- Viridos
- Xyphos Biosciences, Inc.
- Yield10 Biosciences Inc.
- Ziopharm Oncology, Inc.
- Zymergen
- Zymochem Inc.